216 related articles for article (PubMed ID: 22452964)
1. Typical investigational medicinal products follow relatively uniform regulations in 10 European Clinical Research Infrastructures Network (ECRIN) countries.
Gluud C; Kubiak C; Whitfield K; Byrne J; Huemer KH; Thirstrup S; Libersa C; Barraud B; Grählert X; Dreier G; Geismann S; Kuchinke W; Temesvari Z; Blasko G; Kardos G; O'Brien T; Cooney M; Gaynor S; Schieppati A; de Andres F; Sanz N; Kreis G; Asker-Hagelberg C; Johansson H; Bourne S; Asghar A; Husson JM; Demotes-Mainard J
Trials; 2012 Mar; 13():27. PubMed ID: 22452964
[TBL] [Abstract][Full Text] [Related]
2. Compassionate use of interventions: results of a European Clinical Research Infrastructures Network (ECRIN) survey of ten European countries.
Whitfield K; Huemer KH; Winter D; Thirstrup S; Libersa C; Barraud B; Kubiak C; Stankovski L; Grählert X; Dreier G; Geismann S; Kuchinke W; Strenge-Hesse A; Temesvari Z; Blasko G; Kardos G; O'Brien T; Cooney M; Gaynor S; Schieppati A; Serrano M; de Andres F; Sanz N; Hernández R; Kreis G; Asker-Hagelberg C; Johansson H; Asghar A; Husson JM; Demotes J; Gluud C
Trials; 2010 Nov; 11():104. PubMed ID: 21073691
[TBL] [Abstract][Full Text] [Related]
3. Common definition for categories of clinical research: a prerequisite for a survey on regulatory requirements by the European Clinical Research Infrastructures Network (ECRIN).
Kubiak C; de Andres-Trelles F; Kuchinke W; Huemer KH; Thirstrup S; Whitfield K; Libersa C; Barraud B; Grählert X; Dreier G; Grychtol R; Temesvari Z; Blasko G; Kardos G; O'Brien T; Cooney M; Gaynor S; Schieppati A; Sanz N; Hernandez R; Asker-Hagelberg C; Johansson H; Bourne S; Byrne J; Asghar A; Husson JM; Gluud C; Demotes-Mainard J
Trials; 2009 Oct; 10():95. PubMed ID: 19835581
[TBL] [Abstract][Full Text] [Related]
4. [Recording and reporting adverse reactions in clinical trials. New legal provisions according to the 12th Law Amending the German Drug Law (AMG) and the Ordinance on GCP (GCP-V)].
Eckhardt K; Cremer-Schaeffer P; König J; Paeschke N
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2005 Feb; 48(2):173-80. PubMed ID: 15726458
[TBL] [Abstract][Full Text] [Related]
5. Regulatory and operational challenges in conducting Asian International Academic Trial for expanding the indications of cancer drugs.
Hata T; Nakamura K; Yonemori K; Noguchi E; Watanabe M; Sohn J; Lu YS; Yap YS; Tamura K; Fujiwara Y
Clin Transl Sci; 2021 May; 14(3):1015-1025. PubMed ID: 33382914
[TBL] [Abstract][Full Text] [Related]
6. Navigating the maze of requirements for obtaining approval of non-interventional studies (NIS) in the European Union.
Ramirez I
Ger Med Sci; 2015; 13():Doc21. PubMed ID: 26633964
[TBL] [Abstract][Full Text] [Related]
7. [Scientific advice by the nationally competent authority and by the EMEA on the conduct of clinical trials].
Dejas-Eckertz P; Schäffner G
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2005 Apr; 48(4):423-8. PubMed ID: 15830253
[TBL] [Abstract][Full Text] [Related]
8. Clinical Trial Application in Europe: What Will Change with the New Regulation?
Giannuzzi V; Altavilla A; Ruggieri L; Ceci A
Sci Eng Ethics; 2016 Apr; 22(2):451-66. PubMed ID: 26037896
[TBL] [Abstract][Full Text] [Related]
9. GCP inspections in Germany and Europe following the implementation of the Directive 2001/20/EC.
Göbel C; Baier D; Ruhfus B; Hundt F
Ger Med Sci; 2009 Mar; 7():Doc01. PubMed ID: 19675741
[TBL] [Abstract][Full Text] [Related]
10. [Compassionate use of non-approved medicinal products. Legal basis and guidelines].
Sudhop T
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2009 Apr; 52(4):439-43. PubMed ID: 19343282
[TBL] [Abstract][Full Text] [Related]
11. Overview of the Regulatory Oversight Implemented by the French Regulatory Authorities for the Clinical Investigation of Gene Therapy and Cell Therapy Products.
Lucas-Samuel S; Ferry N; Trouvin JH
Adv Exp Med Biol; 2015; 871():73-85. PubMed ID: 26374213
[TBL] [Abstract][Full Text] [Related]
12. [Pediatric drug development: ICH harmonized tripartite guideline E11 within the United States of America, the European Union, and Japan].
Pflieger M; Bertram D
Arch Pediatr; 2014 Oct; 21(10):1129-38. PubMed ID: 25175054
[TBL] [Abstract][Full Text] [Related]
13. Granting marketing authorisation for medicines in South East European countries: the point of view of the authority.
Tomić S; Sucić AF; Martinac AI
Regul Toxicol Pharmacol; 2010; 57(2-3):325-32. PubMed ID: 20385190
[TBL] [Abstract][Full Text] [Related]
14. Impact assessment of the European Clinical Trials Directive: a longitudinal, prospective, observational study analyzing patterns and trends in clinical drug trial applications submitted since 2001 to regulatory agencies in six EU countries.
Hartmann M
Trials; 2012 Apr; 13():53. PubMed ID: 22540886
[TBL] [Abstract][Full Text] [Related]
15. The legal framework governing the quality of (traditional) herbal medicinal products in the European Union.
Kroes BH
J Ethnopharmacol; 2014 Dec; 158 Pt B():449-53. PubMed ID: 25086408
[TBL] [Abstract][Full Text] [Related]
16. [Approval of clinical trials of immunobiological medicinal products at the Paul Ehrlich Institute].
Krafft H; Cichutek K
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2005 Feb; 48(2):168-72. PubMed ID: 15726457
[TBL] [Abstract][Full Text] [Related]
17. Impact of the European Clinical Trials Directive on academic clinical research.
Baeyens AJ
Med Law; 2004; 23(1):103-10. PubMed ID: 15163079
[TBL] [Abstract][Full Text] [Related]
18. The Early Preclinical Development Program for Locally Administered Investigational Medicinal Products in Ophthalmology: Preclinical Data Required for Starting a First-in-Human Clinical Trial in Europe-Basic Considerations and 2 Case Studies.
Toggenburger A; Trönnberg R; Galland A; Mathis GA
Ther Innov Regul Sci; 2018 May; 52(3):321-328. PubMed ID: 29714531
[TBL] [Abstract][Full Text] [Related]
19. US regulation of combination products.
Donawa M
Med Device Technol; 2009 Oct; 20(6):22, 24-5. PubMed ID: 20302139
[TBL] [Abstract][Full Text] [Related]
20. [New drugs and European procedures of approval. The European Agency for the Evaluation of Medicinal Products' role].
Ainsworth MA
Ugeskr Laeger; 2003 Apr; 165(16):1648-9. PubMed ID: 12756819
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
